Skip to main content
. 2021 Jan 14;12(1):85. doi: 10.1038/s41419-020-03370-4

Fig. 6. Combination of CYH33 with MEK/mTORC1/BET inhibitors synergistically suppressed growth of CYH33-resistant cells.

Fig. 6

A CYH33-resistant cells were treated with MEK162/RAD001/OTX015 and CYH33 alone or in combination for 72 h. Cell proliferation was measured with SRB assay and combination index (CI) values were calculated by Calcu Syn software (n = 3). BD CYH33-resistant cells were treated with CYH33 (1 μM, 1 h), MEK162 (1 μM, 1 h) (B), RAD001 (1 μM, 1 h) (C), or OTX015 (1 μM, 24 h) (D) alone or in combination. Cell lysates were then subjected to western blotting with indicated antibodies. Data shown are from at least two independent experiments. C: CYH33, M: MEK162, R: RAD001, O: OTX015.